US4316896A
(en)
*
|
1978-09-07 |
1982-02-23 |
Merck & Co., Inc. |
Aminoacid derivatives as antihypertensives
|
US4698355A
(en)
*
|
1979-08-14 |
1987-10-06 |
University Of Miami |
Anti-hypertensive agents
|
US4690937A
(en)
*
|
1979-08-14 |
1987-09-01 |
University Of Miami |
Anti-hypertensive agents
|
US4690938A
(en)
*
|
1979-08-14 |
1987-09-01 |
University Of Miami |
Anti-hypertensive agents
|
US4690940A
(en)
*
|
1979-08-14 |
1987-09-01 |
University Of Miami |
Anti-hypertensive agents
|
US4695577A
(en)
*
|
1979-08-14 |
1987-09-22 |
University Of Miami |
Anti-hypertensive agents
|
US4698356A
(en)
*
|
1979-08-14 |
1987-10-06 |
University Of Miami |
Anti-hypertensive agents
|
US4690939A
(en)
*
|
1979-08-14 |
1987-09-01 |
University Of Miami |
Anti-hypertensive agents
|
ZA794723B
(en)
*
|
1978-09-11 |
1980-08-27 |
Univ Miami |
Anti-hypertensive agents
|
US4168267A
(en)
*
|
1978-10-23 |
1979-09-18 |
E. R. Squibb & Sons, Inc. |
Phosphinylalkanoyl prolines
|
US4734420A
(en)
*
|
1980-03-05 |
1988-03-29 |
University Of Miami |
Anti-hypertensive agents
|
US4690936A
(en)
*
|
1980-03-05 |
1987-09-01 |
University Of Miami |
Anti-hypertensive agents
|
US4337201A
(en)
*
|
1980-12-04 |
1982-06-29 |
E. R. Squibb & Sons, Inc. |
Phosphinylalkanoyl substituted prolines
|
US4379146A
(en)
*
|
1981-02-17 |
1983-04-05 |
Merck & Co., Inc. |
Substituted phosphonamides as antihypertensives
|
US4374131A
(en)
*
|
1981-04-27 |
1983-02-15 |
E. R. Squibb & Sons, Inc. |
Amino and substituted amino phosphinyl-alkanoyl compounds
|
US4416831A
(en)
*
|
1981-04-27 |
1983-11-22 |
E. R. Squibb & Sons, Inc. |
Amino and substituted amino phosphinylalkanoyl compounds
|
US4416833A
(en)
*
|
1981-05-04 |
1983-11-22 |
E. R. Squibb & Sons, Inc. |
Substituted carbonyl phosphinyl-alkanoyl compounds
|
US4381297A
(en)
*
|
1981-05-04 |
1983-04-26 |
E. R. Squibb & Sons, Inc. |
Substituted carbonyl phosphinyl-alkanoyl compounds
|
EP0070131A1
(en)
*
|
1981-07-09 |
1983-01-19 |
Analytical Research Pharmaceuticals Pty. Ltd. |
Phosphonoalkanoylamino acids
|
US4432971A
(en)
*
|
1981-08-03 |
1984-02-21 |
E. R. Squibb & Sons, Inc. |
Phosphonamidate compounds
|
US4371526A
(en)
*
|
1981-08-21 |
1983-02-01 |
E. R. Squibb & Sons, Inc. |
Phosphinylalkanoyl substituted 4,5-dihydropyrazole-5-carboxylic acid derivatives and hypotensive method and composition
|
US4555506A
(en)
*
|
1981-12-24 |
1985-11-26 |
E. R. Squibb & Sons, Inc. |
Phosphorus containing compounds and use as hypotensives
|
US4560680A
(en)
*
|
1982-03-15 |
1985-12-24 |
E. R. Squibb & Sons, Inc. |
Aminoalkyl and related substituted phosphinic acid angiotensin converting enzyme inhibitors
|
US4452791A
(en)
*
|
1982-03-15 |
1984-06-05 |
E. R. Squibb & Sons, Inc. |
Aminoalkyl and related substituted phosphinic acid angiotensin converting enzyme inhibitors
|
EP0091525A3
(en)
*
|
1982-04-08 |
1984-02-29 |
Analytical Research Pharmaceuticals Pty. Ltd. |
Phosphonoalkanoylamino acids
|
US4448772A
(en)
*
|
1982-04-22 |
1984-05-15 |
E. R. Squibb & Sons, Inc. |
Phosphinylmethylaminocarbonyl imino acid compounds useful for treating hypertension
|
US4560681A
(en)
*
|
1982-04-22 |
1985-12-24 |
E. R. Squibb & Sons, Inc. |
Phosphinylmethylaminocarbonyl imino acid compounds useful for treating hypertension
|
CA1258853A
(en)
*
|
1982-04-30 |
1989-08-29 |
Rudiger D. Haugwitz |
Substituted 4-phenoxy prolines
|
US4703043A
(en)
*
|
1982-06-23 |
1987-10-27 |
E. R. Squibb & Sons, Inc. |
Phosphonyl hydroxyacyl amino acid derivatives as antihypertensive
|
US4452790A
(en)
*
|
1982-06-23 |
1984-06-05 |
E. R. Squibb & Sons, Inc. |
Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives
|
US4616005A
(en)
*
|
1982-06-23 |
1986-10-07 |
E. R. Squibb & Sons, Inc. |
Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives
|
US4567166A
(en)
*
|
1982-07-14 |
1986-01-28 |
E. R. Squibb & Sons, Inc. |
Amino and substituted amino phosphinylalkanoyl compounds useful for treating hypertension
|
US4552889A
(en)
*
|
1983-06-09 |
1985-11-12 |
Eli Lilly And Company |
3-Mercaptomethyl-2-oxo-1-pyrrolidine acetic acids and use for hypertension
|
JPH0624706B2
(ja)
*
|
1985-10-01 |
1994-04-06 |
ミネソタ マイニング アンド マニユフアクチユアリング コンパニ− |
研磨パツド
|
AU632596B2
(en)
*
|
1989-08-21 |
1993-01-07 |
E.R. Squibb & Sons, Inc. |
Phosphonate substituted amino or imino acids useful as antihypertensives
|
DE3939142A1
(de)
*
|
1989-11-27 |
1991-05-29 |
Hoechst Ag |
Verfahren zur oxidation von 2-hydroxy-aethylphosphonsaeuredialkylestern
|
US6011021A
(en)
*
|
1996-06-17 |
2000-01-04 |
Guilford Pharmaceuticals Inc. |
Methods of cancer treatment using naaladase inhibitors
|
US5795877A
(en)
*
|
1996-12-31 |
1998-08-18 |
Guilford Pharmaceuticals Inc. |
Inhibitors of NAALADase enzyme activity
|
US5863536A
(en)
*
|
1996-12-31 |
1999-01-26 |
Guilford Pharmaceuticals Inc. |
Phosphoramidate derivatives
|
US6071965A
(en)
*
|
1996-06-17 |
2000-06-06 |
Guilford Pharmaceuticals Inc. |
Phosphinic alkanoic acid derivatives
|
US6025345A
(en)
*
|
1996-06-17 |
2000-02-15 |
Guilford Pharmaceuticals Inc. |
Inhibitors of NAALADase enzyme activity
|
US6025344A
(en)
|
1996-06-17 |
2000-02-15 |
Guilford Pharmaceuticals Inc. |
Certain dioic acid derivatives useful as NAALADase inhibitors
|
US6054444A
(en)
|
1997-04-24 |
2000-04-25 |
Guilford Pharmaceuticals Inc. |
Phosphonic acid derivatives
|
US5977090A
(en)
*
|
1996-09-27 |
1999-11-02 |
Guilford Pharmaceuticals Inc. |
Pharmaceutical compositions and methods of treating compulsive disorders using NAALADase inhibitors
|
US6046180A
(en)
*
|
1996-06-17 |
2000-04-04 |
Guilford Pharmaceuticals Inc. |
NAALADase inhibitors
|
US6384022B1
(en)
|
1996-06-17 |
2002-05-07 |
Guilford Pharmaceuticals Inc. |
Prodrugs of NAALAdase inhibitors
|
US5672592A
(en)
*
|
1996-06-17 |
1997-09-30 |
Guilford Pharmaceuticals Inc. |
Certain phosphonomethyl-pentanedioic acid derivatives thereof
|
US5902817A
(en)
*
|
1997-04-09 |
1999-05-11 |
Guilford Pharmaceuticals Inc. |
Certain sulfoxide and sulfone derivatives
|
AU725455B2
(en)
|
1996-06-17 |
2000-10-12 |
Guilford Pharmaceuticals Inc. |
Methods of cancer treatment using NAALADase inhibitors
|
US5962521A
(en)
*
|
1997-04-04 |
1999-10-05 |
Guilford Pharmaceuticals Inc. |
Hydroxamic acid derivatives
|
US5981209A
(en)
*
|
1997-12-04 |
1999-11-09 |
Guilford Pharmaceuticals Inc. |
Use of NAALADase activity to identify prostate cancer and benign prostatic hyperplasia
|
US6028216A
(en)
*
|
1997-12-31 |
2000-02-22 |
Guilford Pharmaceuticals Inc. |
Asymmetric syntheses and intermediates for preparing enantiomer-enriched hydroxyphosphinyl derivatives
|
US6121252A
(en)
*
|
1998-03-30 |
2000-09-19 |
Guilford Pharmaceuticals Inc. |
Phosphinic acid derivatives
|
JP4503836B2
(ja)
|
1998-07-06 |
2010-07-14 |
エイザイ インコーポレイテッド |
医薬化合物及び組成物として有用なNAALADase阻害剤
|
US6395718B1
(en)
*
|
1998-07-06 |
2002-05-28 |
Guilford Pharmaceuticals Inc. |
Pharmaceutical compositions and methods of inhibiting angiogenesis using naaladase inhibitors
|
US6265609B1
(en)
|
1998-07-06 |
2001-07-24 |
Guilford Pharmaceuticals Inc. |
Thio-substituted pentanedioic acid derivatives
|
US6313159B1
(en)
|
1999-08-20 |
2001-11-06 |
Guilford Pharmaceuticals Inc. |
Metabotropic glutamate receptor ligand derivatives as naaladase inhibitors
|
ITMI20010395A1
(it)
|
2001-02-27 |
2002-08-27 |
Dompe Spa |
Omega-amminoalchilammidi di acidi r-2-aril-propionici come inibitori della chemiotassi di cellule polimorfonucleate e mononucleate
|
PT1581474E
(pt)
|
2002-12-10 |
2008-12-09 |
Dompe Spa |
Arilcetonas quirais no tratamento de doenças inflamatórias dependentes de neutrófilos
|
PL2519100T3
(pl)
|
2009-12-29 |
2017-09-29 |
Mapi Pharma Limited |
Związki pośrednie i sposoby wytwarzania tapentadolu i pokrewnych związków
|